1187061-62-6
Chemical Structure
GLP-1 receptor agonist 4
- CAS No.: 1187061-62-6
- Formula:C51H44Cl2N4O6
- Molecular Weight:879.82
IUPAC Name: (S)-3-(4'-cyano-[1,1'-biphenyl]-4-yl)-2-((3R,8S)-3-(4-((3,4-dichlorobenzyl)oxy)phenyl)-1-methyl-2-oxo-7-((S)-1-phenylpropyl)-2,3,6,7,8,9-hexahydro-1H-[1,4]oxazino[3,2-g]isoquinoline-8-carboxamido)propanoic acid
InChIKey: ZXJQFMYVTDGFTB-QLEABDMDSA-N
SMILES: O=C(O)[C@@H](NC([C@@H]1CC2=C(CN1[C@H](C3=CC=CC=C3)CC)C=C(O[C@H](C4=CC=C(OCC5=CC=C(Cl)C(Cl)=C5)C=C4)C(N6C)=O)C6=C2)=O)CC7=CC=C(C8=CC=C(C#N)C=C8)C=C7
Biological Activity: GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist extracted from patent WO2009111700A2, compound 87, has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GLP-1 receptor agonist 4 | GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist extracted from patent WO2009111700A2, compound 87, has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
